Pure Global

Follicle-stimulating Hormone - India CDSCO Medical Device Registration

Follicle-stimulating Hormone is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000171_4323fe9395822580d4b76f90fea7c91c_0887c5ff49aa704507195db5f9a27fff. This device is marketed under the brand name CLIA. The license holder is Star Biomed Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Follicle-stimulating Hormone
UID: IMP/IVD/2023/000171_4323fe9395822580d4b76f90fea7c91c_0887c5ff49aa704507195db5f9a27fff

Brand Name

CLIA

License Holder

Star Biomed Pvt. Ltd.

Device Class

Class B

Approving Authority

CDSCO

Product Information

Follicle-stimulating Hormone (CLIA) is a chemiluminescence immunoassay test for the quantitative measurement of circulating Follicle-stimulating Hormone (CLIA) in human serum or plasma, which is intended as an aid to diagnosis of pituitary endocrine function. The assay can be used for samples over the range of 0.2mIU/mL๏ฝž200mIU/mL

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing